共 12 条
- [1] KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease, Am J Kidney Dis., 47, 5 SUPPL. 3, (2006)
- [2] McCormack P.L., Ferumoxytol: In iron deficiency anaemia in adults with chronic kidney disease, Drugs, 72, 15, pp. 2013-2022, (2012)
- [3] Macdougall I.C., Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: Oral or intravenous?, Curr Med Res Opin, 26, 2, pp. 473-482, (2010)
- [4] Locatelli F., Aljama P., Barany P., Et al., Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure, Nephrol Dial Transplant, 19, SUPPL. 2, pp. 1-47, (2004)
- [5] NICE Clinical Guideline 114: Anaemia Management in People with Chronic Kidney Disease, (2011)
- [6] Feraheme (Ferumoxytol Injection): US Prescribing Information, (2011)
- [7] Rienso (Ferumoxytol) 30 Mg/mL Solution for Injection: Summary of Product Characteristics, (2012)
- [8] Spinowitz B.S., Kausz A.T., Baptista J., Et al., Ferumoxytol for treating iron deficiency anemia in CKD, J Am Soc Nephrol., 19, 8, pp. 1599-1605, (2008)
- [9] Fishbane S., Bolton W.K., Winkelmayer W.C., Et al., Factors affecting response and tolerability to ferumoxytol in non-dialysis chronic kidney disease patients, Clin Nephrol, 78, 3, pp. 181-188, (2012)
- [10] Provenzano R., Schiller B., Rao M., Et al., Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients, Clin J Am Soc Nephrol., 4, 2, pp. 386-393, (2009)